Attenuating PI3K isoforms in pancreatic cancer: Focus on immune PI3K gamma

Basset, C; Guillermet-Guibert, J

Guillermet-Guibert, J (reprint author), INSERM, UMR 1037, Equipe 6, 1 Av Jean Poulhes,BP84225, F-31432 Toulouse 4, France.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017; 41 (4): 351

Abstract

Phosphoinositide 3-kinases PI3Ks are major drug targets in oncology. Their role is far from being completely understood in pancreatic ductal adenocarc......

Full Text Link